CMMBVSGTBP• 6 Months (Normalized)
CMMB vs GTBP (Chemomab Therapeutics Ltd. vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 2 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
+7.05%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin CMMB LEADS
+7.05 pts
CMMB outperforming by 7.05 percentage points
CMMBGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | CMMB Price | CMMB Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | +7.05% | $- | - | |
| Sep 28, 2026 | $1.64 | +5.13% | $- | - | |
| Sep 25, 2026 | $2.16 | +38.46% | $- | - | |
| Sep 24, 2026 | $2.20 | +41.03% | $- | - | |
| Sep 23, 2026 | $2.28 | +46.15% | $7.10 | +1477.78% | -1431.63% |
| Sep 22, 2026 | $2.51 | +60.90% | $- | - | |
| Sep 21, 2026 | $2.48 | +58.97% | $7.18 | +1495.56% | -1436.59% |
| Sep 18, 2026 | $2.61 | +67.31% | $7.16 | +1491.11% | -1423.80% |
| Sep 17, 2026 | $2.80 | +79.49% | $7.49 | +1564.44% | -1484.95% |
| Sep 16, 2026 | $2.65 | +69.87% | $7.81 | +1635.56% | -1565.69% |
| Sep 15, 2026 | $2.47 | +58.33% | $9.00 | +1900.00% | -1841.67% |
| Sep 14, 2026 | $2.45 | +57.05% | $11.63 | +2484.44% | -2427.39% |
| Sep 11, 2026 | $2.58 | +65.38% | $8.61 | +1813.33% | -1747.95% |
| Sep 10, 2026 | $2.60 | +66.67% | $6.18 | +1273.33% | -1206.66% |
| Sep 09, 2026 | $2.69 | +72.44% | $5.98 | +1228.89% | -1156.45% |
Page 1 of 9